|
FY2026
12 months to Jan 31, 2026
|
FY2025
12 months to Jan 31, 2025
|
FY2024
12 months to Jan 31, 2024
|
FY2023
12 months to Jan 31, 2023
|
FY2022
12 months to Jan 31, 2022
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses | |||||
| Selling and marketing | |||||
| Research and development | |||||
| General and administrative | |||||
| Other operating (income) expenses | |||||
| Impairment charge | |||||
| Total operating expenses | |||||
| Operating income | |||||
| Financing costs | |||||
| Financing income | |||||
| Foreign exchange (gain) loss on long-term debt | |||||
| Income before income taxes | |||||
| Income tax expense | |||||
| Net income from continuing operations | |||||
| Net loss from discontinued operations | |||||
| Net income (loss) | |||||
| Attributable to shareholders | |||||
| Attributable to non-controlling interest | |||||
| Basic earnings per share - continuing operations | |||||
| Diluted earnings per share - continuing operations | |||||
| Basic loss per share - discontinued operations | |||||
| Diluted loss per share - discontinued operations | |||||
| Basic earnings (loss) per share | |||||
| Diluted earnings (loss) per share |
Loading...